Immunoglobulin heavy chain sequence analysis in Waldenström's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance

Clinical Lymphoma and Myeloma

Volumn 7, Issue 1, 2006, Pages 70-72

  Rollett, Rebecca A ^a   Wilkinson, Elizabeth J ^a   Gonzalez, David ^a   Fenton, James A L ^a   Short, Michael A ^a   Evans, Paul A S ^a   Rawstron, Andy C ^a   Owen, Roger G ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Intraclonal variation; Lymphoplasmacytic lymphoma; Sequence analysis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M;

AGED; ARTICLE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MEMORY CELL; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOGENESIS; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; WALDENSTROEM MACROGLOBULINEMIA;

EID: 33748320722     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2006.n.042     Document Type: Article

References (15)

1. Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998; 91:4292-4299.
2. Sahota SS, Leo R, Hamblin TJ, et al. Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 1996; 87:746-755.
3. Owen RG, Treon SP, Al-Kalib A, et al. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Semin Oncol 2003; 30:110-115.
4. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17:2257-2317.
5. Sahota SS, Forconi F, Ottensmeier CH, et al. Waldenström macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 2002; 100:1505-1507.
6. Kriangkum J, Taylor BJ, Treon SP, et al. Clonotypic IgM V/D/J sequence analysis in Waldenström macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B-cells in peripheral blood. Blood 2004; 104:2134-2142.
7. Walsh SH, Laurell A, Sundström G, et al. Lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. Leuk Res 2005; 29:729-734.
8. Owen RG, Barrans SL, Richards SJ, et al. Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol 2001; 116:420-428.
9. Owen RG. Developing diagnostic criteria in Waldenström's macroglobulinemia. Semin Oncol 2003; 30:196-200.
10. San Miguel JF, Vidriales MB, Ocio E, et al. Immunophenotypic analysis of Waldenström's macroglobulinemia. Semin Oncol 2003; 15:187-195.
11. Schop RF, Kuehl WM, Van Wier SA, et al. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100:2996-3001.
12. Avet-Loiseau H, Garand R, Lode L, et al. 14q32 Translocations discriminate IgM multiple myeloma from Waldenström's macroglobulinemia. Semin Oncol 2003; 30:153-155.
13. Ackroyd S, O'Connor SJ, Owen RG. Rarity of IgH translocations in Waldenström macroglobulinemia. Cancer Genet Cytogenet 2005; 163:77-80.
14. Sahota SS, Forconi F, Ottensmeier CH, et al. Origins of the malignant clone in typical Waldenström's macroglobulinemia. Semin Oncol 2003; 30:136-141.
15. Rawstron AC, Fenton JA, Gonzalez D, et al. Accurate prediction of outcome for IgG and IgA monoclonal gammopathy of undetermined significance patients using flow cytometry. Haematologica 2005; 90(suppl 1):196 (Abstract #1305).